In 38 cases of prosthetic valve endocarditis, 19 were early cases (onset < 60 days after insertion of prosthesis) and 19, late cases (onset> 60 days). Nine late cases had onsets 12 to 53 months after surgery. The sources or predisposing factors in late cases included dental disease or manipu-
lation; genitourinary tract procedures; and skin, urinary, or wound infections. In contrast, most early cases were secondary to complications of operation. Streptococci were the most common organisms causing late endocarditis, whereas staphylococci were most common among early cases. Four of the six patients who survived early onset were treated with antibiotics alone; the others, with antibiotics plus reoperation. In contrast, seven of the 11 late cases that survived were treated with antibiotics alone; the other four, with antibiotics plus reoperation. The lower mortality (42% vs 68%) in the late group probably reflects the less virulent infecting organisms and the better clinical condition of the hosts. Regardless of whether prosthetic valve endocarditis occurs early or late, intensive and prolonged administration of appropriate antibiotics together with aggressive surgical reintervention in selected situations appears necessary for cure. Any patient who has a prosthetic valve and undergoes any procedure likely to produce bacteremia should receive antibiotic prophylaxis in an attempt to prevent late endocarditis.
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Beall prosthesis ALTHOUGH perioperative prophylactic antibiotics may have reduced the incidence of certain types of infection following prosthetic valve implantation, endocarditis remains a serious and sometimes fatal complication. Since the initial recommendation by Geraci et al.' that prophylactic antibiotics be used in an attempt to decrease the incidence of prosthetic valve endocarditis, several investigators have suggested the apparent efficacy of various prophylactic regimens.2 3 An incidence of staphylococcal endocarditis of less than 1% was reported when antistaphylococcal prophylaxis was Antibiotics employed. Nevertheless, staphylococcal species remain the most common cause of prosthetic valve endocarditis, especially in the early postoperative period. 4 5 In addition, a significant number of cases are due to other species of bacteria. 6' 7 The presumptive diagnosis of prosthetic valve endocarditis in all patients with bacteremia and a prosthetic valve has recently been questioned by Sande et al. 8 These authors suggested that not all bacteremias in such patients represent infection of the valve, particularly when there is no hemodynamic instability or evidence of valve dysfunction and when the bacteremia is due to a gram-negative bacillus. Consequently, in this situation the assumption that endocarditis is present may be invalid, and prolonged antibiotic therapy may not be necessary. 8 9 The purpose of this paper is to analyze 38 cases of prosthetic valve endocarditis, the single largest recorded series from one hospital. Emphasis will be given to 19 of these cases with a heretofore uncommon infectious complication of prosthetic valve insertion, namely, late endocarditis.
Materials and Methods
From January, 1964, through June, 1971, valve replacements were performed in 1,671 patients at The Massachusetts General Hospital. Some patients received more than one prosthetic valve at the time of initial operation. During this period, prosthetic valve endocarditis occurred in 36 patients. One of these patients had two distinctively different episodes and his history is treated as two cases. One other patient is included whose prosthetic valve was inserted elsewhere but who required subsequent valve replacements at The Massachusetts General Hospital.
No attempt was made to review the records of all 1,671 patients who received valve prostheses. Since the Cardiac Surgery, Cardiology, and Infectious Disease Units work closely together, it is believed that the Infectious Disease Unit was aware of every hospitalized patient with prosthetic valve endocarditis during the period of study. Each of the 38 cases of prosthetic valve endocarditis was seen during the illness by one of the members of the Infectious Disease Unit. It is possible that patients who returned to their referring physician or hospital after valve replacement and who subsequently developed late endocarditis might not have been readmitted to The Massachusetts General Hospital and therefore might not be included in this series.
A minimum of five sets of blood cultures were obtained from each patient with suspected endocarditis. Each set consisted of 5 ml of blood inoculated into each of two bottles, one containing 100 ml of thioglycollate broth and the other containing 100 ml of dextrose phosphate broth. All blood cultures were kept for 14 days.
Any patient with a prosthetic valve, bacteremia (due to the same organism) demonstrated on two or more blood cultures, and a clinical illness consistent with endocarditis was considered to have prosthetic valve endocarditis. Patients in whom endocarditis occurred within 60 days of the original prosthetic valve replacement were defined as having "early" endocarditis. Patients in whom endocarditis occurred 60 days or more after insertion of the prosthetic valve were defined as having 'late" endocarditis. Sixty days was arbitrarily chosen in an attempt to separate those patients with infection probably related to operation from those whose infection probably arose from a later source. Consequently, this patient has been considered as two cases (Nos. 30 and 30A). In contrast, several patients had recurrent endocarditis due to the same organism or two pathogens infecting the valve without a symptom-free interval; these patients have been considered to be single cases of endocarditis with multiple episodes of infection. Because similar clinical information is available on both the previously described 12 cases and the 26 more recent cases, and because all 38 cases are from the same hospital, it appears appropriate to analyze the total 38 cases herein.
Results

Analysis of Cases
The ages of the 37 patients (38 cases) range from 25 years to 73 years. Twenty-seven of the patients were males and ten were females.
Initial Operative Procedures
Of 28 patients who received a single valve prosthesis, 21 underwent aortic valve replacement and 7 underwent mitral valve replacement. Seven patients underwent double valve replacement with implantation of both aortic valve and mitral valve prostheses. Two patients underwent replacement of the aortic, mitral, and tricuspid valves. Starr-Edwards prostheses were used in all patients except two. One of the patients who underwent triple valve replacement received a Beall prosthesis for the tricuspid valve, and one patient who underwent mitral valve replacement received a Kay-Shiley prosthesis.
Perioperative Antibiotic Prophylaxis
All patients received prophylactic antibiotics for at least four days, and all but two received antistaphylococcal drugs. Administration of parenteral antibiotics was begun 12 hours before and then administered during and after operation in all but three cases. In these three, one of the antibiotics was given orally after the second postoperative day. The specific antibiotic regimens of the 12 patients with endocarditis during 1964 through 1968 have been previously described.10 Eight of these patients received both methicillin and streptomycin, and the remaining four were on antimicrobial regimens selected either on the basis of a history of penicillin allergy or of a preexisting infection. Among the 25 recent patients (tables 1 and 2), 16 received a combination of streptomycin with methicillin or cephalothin. Another four patients received oxacil-Circulation, Volume XLVIII, August 1973 lin alone, two patients received cephalothin alone, and one received tetracycline alone. Another patient, who underwent aortic valve replacement to repair valvular insufficiency secondary to preexisting streptococcal endocarditis, received penicillin, oxacillin, and gentamicin. A final patient, who underwent aortic valve replacement because of a paravalvular leak secondary to endocarditis caused by a nongroupable streptococcus, received a combination of penicillin, methicillin, and streptomycin.
Source of Infection and/or Predisposing Factors
Among the 19 patients with early endocarditis, nine had as a probable source of infection a septic complication of the original operation (table 3) .
These included a contaminated intravenous catheter, postoperative pneumonia, and postoperative wound infection. In all nine of these patients, cultures of specimens obtained at the site of infection yielded the same organism which was subsequently isolated from the blood.
Three patients (Cases 4, 19, 22) in the early group had endocarditis before insertion of the prosthetic valve; infection recurred with the previously isolated organism in two. One of these (Case 4) had preoperative Klebsiella endocarditis. Two days following surgery Klebsiella bacteremia developed and the patient died; cultures of the prosthetic valve yielded Klebsiella. The other patient (Case 22) had pre-existing endocarditis due to Staphylococcus epidermidis; aortic insufficiency necessitated aortic valve replacement. Culture of the excised valve revealed S. epidermidis. One month after the original valve replacement S. epidermidis bacteremia and endocarditis recurred.
One patient (Case 24) in the early group underwent multiple tooth extractions with penicillin and oxacillin prophylaxis nine days after aortic valve replacement. Two weeks later blood cultures contained diphtheroids; the patient died within 24 hours and autopsy revealed diphtheroid endocarditis. Diphtheroid endocarditis also developed in a second patient (Case 23); a periapical dental abscess was the apparent primary focus of infection.
Immediate postoperative paravalvular leak may have predisposed to the localization of bacteria on the prosthetic valve in four patients (Cases 13, 16, 19, 22) . A source of infection or predisposing factor was not identified for three patients.
In contrast to the early group of patients whose bacteremia and valve infection was almost always related to a complication of the operation, the Circulation, Volume XLVIII, Augurst 1973 predisposing factor in patients with late endocarditis often appeared to be an incidental septic event. Three patients (Cases 8, 9, 34) had either a urinary infection or had undergone genitourinary manipulation prior to the onset of bacteremia; one patient (Case 35) had squeezed a nasal furuncle and two patients (Cases 31 and 33) had wound infections. Streptococcal bacteremia and endocarditis developed in three (Cases 11, 30, 37) of four patients who had undergone either cleaning, scaling, filling, or extraction of teeth; the fourth patient's (Case 32) teeth were in poor condition and Klebsiella bacteremia developed three weeks after dental manipulation. Only one of these four patients (Case 37) had received antimicrobial prophylaxis at the time of dental manipulation. She had been given prophylactic penicillin; one month later group Dstreptococcal bacteremia occurred. Endocarditis caused by a nongroupable streptococcus occurred in a fifth patient (Case 25), who had not undergone dental manipulation but who did have severe dental caries. In seven of the patients in the late group, no predisposing factor or source of sepsis could be identified.
Bacteriology
The organisms causing endocarditis in both groups of patients are shown in table 4. Among the 19 early cases there were 21 episodes of endocarditis. One of the patients (Case 19) in the early group had three episodes caused by two different organisms. Following the original operation, Serratia endocarditis developed; this was followed by two episodes of Candida endocarditis.
There were 20 episodes of endocarditis among the 19 late cases. Two patients each had two episodes of endocarditis. In one patient (Case 30), endocarditis due to a nongroupable streptococcus responded well to antibiotics alone; S. aureus endocarditis occurred eight and one-half months later. This patient has been considered as two separate cases of endocarditis (Cases 30 and 30A). The other patient (Case 35) had two episodes of S. epidermidis infection of the aortic valve which were unsuccessfully treated with antibiotics plus three reoperations.
Among the 20 late episodes there were 16 infections due to gram-positive cocci; only nine of the 21 episodes of early endocarditis were due to gram-positive cocci. In contrast with the early group in which seven of the infections were due to staphylococci, ten of the late infections were due to streptococci. Of the five patients with Candida . .. S *. *. C.) C.) .'t. . endocarditis, four were in the early and one in the late group.
Clinical Features
Fever was present in all 21 episodes among the early group, a prosthetic regurgitant murmur in 13, Similarly, because of the presence of an indwelling Foley catheter during the early postoperative period, hematuria was difficult to interpret.
Fever was present in all 20 episodes of late endocarditis. A prosthetic regurgitant murmur was noted in 12, splenomegaly in 12, and skin or conjunctival petechiae in 12. Roth spots, Osler nodes or Janeway lesions were observed in only four patients. Leukocytosis (>12,000 WBC) was present in 14 of the 20 episodes, whereas anemia was present in 18 and hematuria (more than five red blood cells per high power field) was present in 15.
Treatment and Outcome
Twenty-one of the 37 patients (including Case 30A) died as a direct result of prosthetic valve infection. Thirteen of the deaths occurred among the 19 cases with early endocarditis (68%) compared with only eight deaths among the 19 cases of late endocarditis (42%) (table 5). Among the six survivors in the early group, four patients were treated with antibiotics alone and the other two were treated with antibiotics plus reoperation. In contrast, among the 11 survivors in the late group (including Case 30), 7 were treated with antibiotics alone and four required reoperation(s) plus antibiotics. Among the 14 patients in the early group treated with antibiotics alone, only four survived whereas of the 13 cases in the late group treated with antibiotics alone, seven survived. The periods of follow-up for the 11 survivors listed in tables 1 and 2 range from 3% to 24 months.
Of the four early survivors treated with antibiotics alone, three (Cases 7, 15, 17) had infections due to S. epidermidis and one (Case 21) due to S. Circulation, Volume XLVIII, August 1973 aureus. All received parenteral antibiotics for at least five weeks. Among the seven survivors in the late group treated with antibiotics alone, five had infections due to streptococci (nongroupable streptococcus in three, Cases 25, 29, 30, and group Dstreptococcus in two, Cases 8 and 37); one was infected by Mima (Case 10) and another by Klebsiella (Case 32). All episodes were treated with a minimum of four weeks of parenteral antibiotics. In 11 patients, treatment consisted of both antibiotics and reoperation. In ten of the 11, paravalvular leak was the indication for reoperation. In the eleventh patient (Case 34) the indication was persistent infection and cerebral embolus. Three patients underwent more than one reoperation. One patient (Case 19) underwent two additional operations following initial valve replacement in an attempt to eliminate paravalvular leak and Candida endocarditis. The cultures of materials excised at reoperation in both instances were positive. Two patients (Cases 22 and 35) with S. epidermidis endocarditis underwent three additional aortic valve replacements after the initial operation in an attempt to control the hemodynamic complications due to paravalvular leak. In both patients, cultures of the excised prosthesis at the second and third reoperations revealed the infecting organism. In spite of prolonged antibiotic therapy and a fourth operation in each patient, both died as a result of infection. Among the six surviving patients (Cases 1, 9, 11, 23, 34, 36) who were treated with antibiotics plus reoperation, cultures at reoperation were positive in two (Cases 34 and 36).
Post Mortem Findings
Autopsies were performed on 16 of the 21 patients who died (table 6). In 13 of the 16 there were vegetations on the prosthetic valve, and in seven, there was at least minimal dehiscence of the involved prosthesis. In nine patients, cultures of the valve or vegetations revealed the same organism which had been present in premortem blood. In three other patients whose valves were not cultured, culture of heart blood at autopsy was positive for the same organism.
Discussion
Many of the reports of prosthetic valve endocarditis have focused on patients whose infection developed within the first month or two after prosthetic valve replacement.2 7 '1 Staphylococci have been the species most commonly involved, particularly in the early postoperative period (table  7) . Among our 19 early cases (21 episodes of endocarditis), 7 episodes were caused by staphylococci (S. aureus in 3 and S. epidermidis in 4). The other two major groups of organisms among our early patients were gram-negative bacilli and Candida. Geraci et al.' first suggested the use of prophylactic antibiotics at the time of prosthetic valve replacement, based on a 10% incidence of staphylococcal prosthetic valve endocarditis in patients who had received no antibiotics perioperatively. Subsequently. Nelson et al.12 compared three groups of patients: one group that received no prophylactic antibiotics, a second that received streptomycin and a small amount of penicillin, and a third that received oxacillin, streptomycin, and a large amount of penicillin. Whereas the incidence of endocarditis in the first two groups was 4.6% and 1.2% respectively, no cases of endocarditis occurred in the third group of 76 patients. Other investigators have reported similar experiences. Amoury et al. 2 suggested that an augmented and prolonged prophylactic antibiotic program in patients undergoing prosthetic valve replacement was effective in preventing staphylococcal endocarditis. Stein, Harken, and Dexter3 reported a decrease in mortality from endocarditis from 3.7% to 0.2% and total elimination of staphylococcal endocarditis by the institution of a prophylactic regimen consisting of intravenous methicillin (4-8 gm/day) followed by oral oxacillin (2 gm/day) for a total of at least ten days. However, none of these reports was based upon a controlled alternate case study. Moreover, each utilized data collected from cases studied during different periods, a technique which often fails to account for variables other than those being studied.
Although the incidence of staphylococcal endocarditis following prosthetic valve replacement may be decreased by use of prophylactic antibiotics, it is by no means eliminated. The incidence of early endocarditis in our series was only 1.1%, but seven of the 21 episodes were attributable to staphylococci. All seven patients received antistaphylococcal prophylaxis immediately preoperatively and for four to six days postoperatively. Among 11 episodes of prosthetic valve endocarditis reported by Okies et al.,4 7 were caused by staphylococcus species and none of these patients received antistaphylococcal prophylaxis. Similarly, staphylococci were the etiological agents in five patients with early endocarditis reported by Fraser et al. 5 ; chloramphenicol had been the only antibiotic employed. These data suggest a role for potent antistaphylococcal drugs in any perioperative antibiotic program for prosthetic valve recipients. However, sufficient data are not available to accurately assess the tmpact of antistaphylococcal prophylaxis on the over-all incidence of early prosthetic valve endocarditis and more specifically whether antistaphylococcal prophylaxis causes a predisposition to increased incidence of gram-negative and fungal endocarditis. Our series and those of other investigators (table 7) suggest that prosthetic valve endocarditis due to organisms other than staphylococei is a serious problem in the early postoperative period.
Goodman et al. ' 3 did perform a double blind study of prophylactic antibiotics in patients undergoing cardiovascular surgery. However, two cases of pneumococcal endocarditis in the placebo group caused these investigators to abandon the placebo regimen. Furthermore, the specific antibiotic prophylactic regimens (penicillin-streptomycin or oxacillin alone) not only did not appear to alter the frequency of postoperative infection, but may have determined the types of organisms that caused infection. More recently, Conte et al.14 reported the 3  1  5  2  3  Total  65  14  24  4  13  10  26  1  13  3  3  6 *Defined as endocarditis occurring less than 30-60 days after valve replacement.
Circulation, Volume XLVIII, August 1973 results of a prospective double blind comparison of single-dose intraoperative cephalothin versus multiple-dose (pre-, intra-and postoperative) cephalothin as prophylaxis in 64 patients undergoing cardiac surgery with cardiopulmonary bypass. Prosthetic valve endocarditis developed in only one study patient, a recipient of single dose cephalothin; this low incidence of endocarditis as a complication precludes any judgment about the comparative efficacy of a shortvs long-duration regimen in preventing postoperative endocarditis. However, the authors emphasize that the multiple-dose, longduration regimen may have predisposed patients to a more resistant group of organisms causing other major postoperative infections, such as pneumonia or wound infection. In addition to the use of prophylactic antibiotics, other measures have been suggested to eliminate the sequelae of intraoperative bacteremia. These include the use of nonwettable sutures and clothcovered prostheses as well as shorter operative time." '1 Blakemore et al.'6, in a study of 32 patients undergoing cardiopulmonary bypass, found that the extracorporeal unit was contaminated in 75% of the cases. The major source of contaminatioin was the coronary suction linie. Organisms isolated included S. epidermidis, diphtheroids, alpha-hemolytic streptococci, gram-negative bacilli (Enterobacter, Serratia, Alcaligenes, and Mima), and fungi (Candida and Aspergillus). These data support an earlier study in which 1,555 blood cultures were obtained from five different sites during 383 open heart procedures.17 Seven and one-half percent of the cultures yielded S. epidermidis and 0.8 percent, diphtheroids. The two sites which yielded the most positive cultures were the extracorporeal pump tubing and the coronary sucker.
This risk of intraoperative contamination is illustrated in four of our patients with early endocarditis. Each had immediate postoperative paravalvular leakage; this probably predisposed to the localization of infection on or about the prosthesis. The infecting organisms were Candida species, Serratia, and S. epidermidis, organisms previously demonstrated in contaminated extracorporeal units. '6, 17 Sande et al. 8 have recently emphasized that all patients with prosthetic valves and bacteremia may not have prosthetic valve endocarditis. In a group of patients with 13 episodes of bacteremia occurring three to 85 days after operation, nine involved gram-negative organisms. Paravalvular leak developed in none of these nine patients, and in all nine Circulation, Volume XLVIII, August 1973 a probable extracardiac source for bacteremia was identified. None of the 13 episodes was believed to be proven endocarditis. In four there was no pathological evidence of prosthetic valve infection at autopsy, and in the other nine there was no clinical evidence of prosthetic valve infection. The authors concluded that valve prostheses may be repeatedly exposed to gram-negative bacilli without the development of infection and that some of the cases of gram-negative prosthetic valve endocarditis previously reported may not represent true endocarditis.
Our five patients with gram-negative bacteremia and presumed endocarditis in the early postoperative period differ from those described by Sande et al. At least four of the five did have infection on the prosthetic valve. One patient with Klebsiella bacteremia had had Klebsiella endocarditis prior to operation and Klebsiella bacteremia recurred postoperatively. The patient died; there were vegetations on the prosthesis and Klebsiella was cultured from the valve. Two patients with Pseudomonas bacteremia and endocarditis died and had Pseudomonas on the prostheses at autopsy. Two of these three patients had paravalvular leak. Persisting Serratia bacteremia developed in a fourth patient ten days after insertion of an aortic valve prosthesis (18 positive blood cultures over a 24-day period). In addition, he had a murmur of aortic insufficiency, petechiae, and renal failure. The fifth patient may have been similar to those in the group described by Sande and coworkers. Serratia was recovered not only from blood but also from urine and a central venous catheter. Although the bacteremia was persistent, no other stigma of endocarditis appeared; death followed development of pneumonia and renal failure. Autopsy was not performed.
While patients with a prosthetic valve may have gram-negative bacteremia without endocarditis, our data suggest that a patient with confirmed bacteremia regardless of the organism) and a prosthetic valve should be considered as having prosthetic valve endocarditis and should be managed as such. Although Sande et al. 8 recommend that only shortterm (10 to 14 days) antibiotic therapy be given to patients with gram-negative bacteremia and no valvular dysfunction in the early postoperative period, in fact, the seven survivors (in their group of 13 patients presumed not to have endocarditis) received a median of 36 days of antibiotic therapy.
We agree with this latter course of treatment and agree with Edwards'8 that prolonged treatment with appropriate antibiotics and reoperation, if valvular dysfunction developes, constitutes the preferred therapeutic approach. Obviously, every effort should also be made to identify and eliminate any other sources of infection such as mycotic aneurysm or a cryptogenic abscess.
The mortality of our cases of early endocarditis was 68%, a figure similar to that reported by others2 4, 6 but in contrast to the lower mortality in our late group (42%). The higher mortality in the early group may be due to at least three factors: immediate postoperative valvular dysfunction, the debilitated state of the postoperative patient, and the more virulent and resistant organisms causing infection in this group. All five of our patients with Candida infection died; others have emphasized the almost universally fatal outcome of Candida prosthetic valve endocarditis.19 20 Of the six survivors in the early group, four were treated with antibiotics alone. There were ten other patients in the early group who were treated with antibiotics alone but who died. Reoperation, in addition to medical therapy with antibiotics, was carried out in five patients in the early group; in each case the indication for reoperation was a paravalvular leak predisposing to congestive heart failure. Although combined therapy was curative in only two of the five patients, reoperation has been increasingly employed in certain patients with prosthetic valve infection.4 11, 21 There are several case reports of successful early replacement of infected valve prostheses. [22] [23] [24] Patients who have signs and symptoms of hemodynamic instability as manifested by development of paravalvular leak or progressive heart failure, systemic embolization, or persistent infection should be strongly considered for early reoperation, even at the risk of higher morbidity and mortality than at initial operation and at the risk of suturing the new prosthesis into an infected area.
In both of our patients with early endocarditis who survived reoperation, culture of the excised valve was negative. However, at least three other early cases with successful valve replacement during continuing active infection have been reported.21 22 There has not been an increased with valve replacement in patients with active endocarditis. Results in these patients, whose infections are similar although not identical to those of the patients with prosthetic valve endocarditis, lend support to the concept of an aggressive surgical approach in certain patients with infected valve prostheses.
Whereas early postoperative prosthetic valve endocarditis is a well-recognized complication of valve replacement, late prosthetic valve endocarditis has been reported infrequently.2-7 11, 28, 29 Our 19 cases of late endocarditis represent the single largest group heretofore reported. The bacteriology of our late cases contrasts with that of the early cases and more nearly resembles that of classical subacute bacterial endocarditis.30 S In the combined series of 26 cases of late prosthetic valve endocarditis compiled from the literature (table 7) , only three cases were due to streptococci and 14 others to staphylococci. Regardless of which group of late cases is considered, the organisms are generally less virulent than those causing early endocarditis. Furthermore, the bacteriology is somewhat predictable if one considers the factors which predispose to late endocarditis in patients with prosthetic valves. In contrast to the early cases, the recognized sources of infection in the late group are not related to operation but to such factors as dental and genitourinary manipulation.
The clinical features in the early and late groups are very similar. Fever was present in all of the late group patients and clinical evidences of endocarditis (for example, splenomegaly and petechiae) in approximately one half, just as with the early cases.
The most compelling reason for calling attention to patients with late prosthetic valve endocarditis is to reemphasize the importance of prophylactic antibiotics in this group of patients during those periods when they are in special danger of acquiring bacteremia. Of the ten episodes of late endocarditis caused by streptococci, bacteremia in six appeared to originate from the oral cavity or genitourinary tract and was probably preventable in each case.
In patients with prosthetic valves who undergo any manipulation likely to produce a transient bacteremia, adequate prophylaxis during and after the procedure is imperative. Such manipulations might include dental procedures, minor skin surgery, genitourinary procedures, or any operation through a contaminated field. Furthermore, patients with prosthetic valves and localized infection of the skin or urinary tract should receive immediate Circulation, Volume XLVIII, August 1973 medical attention and should be given appropriate antibiotics. General recommendations for prophylactic regimens have been provided.3233 In addition, the prescribing physician must consider the "normal" bacterial flora of the involved body area, utilize any available culture and sensitivity data, and view every patient and procedure individually. Hopefully, by such an approach, the incidence of prosthetic valve endocarditis occurring in the late postoperative period can be reduced.
